Novo Nordisk Says Officials Not Qualified To Doubt Drug Bills
By Ben Adlin · October 21, 2025, 10:45 PM EDT
Attorneys for Novo Nordisk Inc. on Tuesday sought to undercut witness testimony that Medicaid claims in Washington state for the company's hemophilia drug NovoSeven were shockingly high, leading one state auditor...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login